GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JZJ Chain Drugstore Corp (SHSE:605266) » Definitions » Return-on-Tangible-Equity

JZJ Chain Drugstore (SHSE:605266) Return-on-Tangible-Equity : 53.14% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is JZJ Chain Drugstore Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. JZJ Chain Drugstore's annualized net income for the quarter that ended in Mar. 2024 was ¥209 Mil. JZJ Chain Drugstore's average shareholder tangible equity for the quarter that ended in Mar. 2024 was ¥393 Mil. Therefore, JZJ Chain Drugstore's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was 53.14%.

The historical rank and industry rank for JZJ Chain Drugstore's Return-on-Tangible-Equity or its related term are showing as below:

SHSE:605266' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 11.59   Med: 34.02   Max: 134.26
Current: 114.61

During the past 10 years, JZJ Chain Drugstore's highest Return-on-Tangible-Equity was 134.26%. The lowest was 11.59%. And the median was 34.02%.

SHSE:605266's Return-on-Tangible-Equity is ranked better than
87.99% of 541 companies
in the Healthcare Providers & Services industry
Industry Median: 10.62 vs SHSE:605266: 114.61

JZJ Chain Drugstore Return-on-Tangible-Equity Historical Data

The historical data trend for JZJ Chain Drugstore's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JZJ Chain Drugstore Return-on-Tangible-Equity Chart

JZJ Chain Drugstore Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.91 23.58 19.54 44.00 134.26

JZJ Chain Drugstore Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 107.24 117.68 160.87 149.82 53.14

Competitive Comparison of JZJ Chain Drugstore's Return-on-Tangible-Equity

For the Pharmaceutical Retailers subindustry, JZJ Chain Drugstore's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JZJ Chain Drugstore's Return-on-Tangible-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, JZJ Chain Drugstore's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where JZJ Chain Drugstore's Return-on-Tangible-Equity falls into.



JZJ Chain Drugstore Return-on-Tangible-Equity Calculation

JZJ Chain Drugstore's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=414.412/( (251.511+365.801 )/ 2 )
=414.412/308.656
=134.26 %

JZJ Chain Drugstore's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=209.04/( (365.801+420.973)/ 2 )
=209.04/393.387
=53.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


JZJ Chain Drugstore  (SHSE:605266) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


JZJ Chain Drugstore Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of JZJ Chain Drugstore's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


JZJ Chain Drugstore (SHSE:605266) Business Description

Traded in Other Exchanges
N/A
Address
No. 10, Qiying Street, Union Street, Panlong District, Yunnan Province, Kunming, CHN, 650224
Jianzhijia Pharmaceutical Chain Group Co Ltd is engaged in the retail chain business of health products such as medicines, health foods, personal care products, household health products, convenience foods, and daily consumables and provides related professional services.
Executives
Jin Yu Mei Supervisors
Chai Zhi Qi senior management
Shi Yan Chun senior management
Hu Yu Ming senior management
Fang Li Supervisors
Sun Li Supervisors
Jiang Yan Yin senior management
Li Heng Director
Zhang Yun Hong Director
Wang Yan Ping Director
Lan Bo Directors, senior managers
Yan Wen senior management

JZJ Chain Drugstore (SHSE:605266) Headlines

No Headlines